# SOCS7

## Overview
The SOCS7 gene encodes the suppressor of cytokine signaling 7 protein, a member of the SOCS family known for its role in the negative regulation of cytokine signaling pathways, particularly the JAK/STAT pathway. The SOCS7 protein is characterized by its distinct molecular structure, which includes a C-terminal SOCS-box, a central SH2 domain, and an N-terminal domain. These structural features facilitate its involvement in various cellular processes, including insulin signaling and cytoskeletal organization. SOCS7 functions as an adaptor protein, interacting with multiple signaling molecules and influencing pathways related to glucose homeostasis, cellular stress responses, and inflammation. Its regulatory roles are significant in maintaining normal metabolic processes and have implications in conditions such as obesity, type 2 diabetes, and cancer (Fu2020PTPN14; Martens2004The; Banks2005Deletion).

## Structure
The SOCS7 protein, also known as suppressor of cytokine signaling 7, is characterized by a distinct molecular structure comprising several domains. It includes a C-terminal SOCS-box, a central SH2 domain, and an N-terminal domain. The N-terminal domain is notably the longest among SOCS proteins and contains several poly-proline areas and a putative nuclear export sequence (NES) between amino acids 56 and 65 (Martens2004The). The SOCS-box, located between amino acids 509 and 552, is involved in protein degradation pathways (Martens2004The).

A unique feature of SOCS7 is a 34 amino acid deletion corresponding to exon 4, likely due to alternative splicing, occurring after amino acid 321 (Martens2004The). The human SOCS7 (hSOCS7) is highly homologous to the mouse SOCS7 (mSOCS7), with a 96% amino acid identity overall. However, hSOCS7 lacks 34 amino acids in the N-terminal region and has 27 additional amino acids at the C-terminus compared to mSOCS7 (Martens2004The).

The SH2 domain facilitates binding to phosphorylated tyrosine residues, which is crucial for its role in cytokine signaling regulation (Fu2020PTPN14). The SOCS7 protein has a molecular weight of 64 kDa (Martens2004The).

## Function
SOCS7 (suppressor of cytokine signaling 7) is a member of the SOCS family involved in the negative regulation of cytokine signaling pathways, particularly the JAK/STAT pathway. In healthy human cells, SOCS7 plays a crucial role in modulating insulin signaling and glucose homeostasis. It interacts with key molecules in the insulin signaling pathway, such as the insulin receptor (INSR) and insulin receptor substrates (IRS1 and IRS2), to regulate their stability and activity. SOCS7 promotes the ubiquitination and proteasomal degradation of IRS1, thereby modulating insulin sensitivity and maintaining glucose homeostasis (Banks2005Deletion).

SOCS7 is also involved in cellular stress responses and is active in both the cytoplasm and nucleus. It interacts with the actin cytoskeleton through vinexin, a cytoskeletal protein, suggesting a role in cytoskeletal organization and cellular signaling processes. This interaction is facilitated by the SH2 domain of SOCS7, which binds to vinexin, indicating its involvement in cell-cell and cell-extracellular matrix junctions (Martens2004The).

In terms of organismal outcomes, SOCS7's regulatory functions in insulin signaling are significant for maintaining normal metabolic processes, potentially influencing conditions like obesity and type 2 diabetes (Banks2005Deletion).

## Clinical Significance
Mutations and alterations in the expression of the SOCS7 gene have been implicated in several diseases and conditions. SOCS7 plays a significant role in insulin signaling, and its deficiency can lead to enhanced insulin sensitivity and altered glucose homeostasis. In Socs7-deficient mice, there is increased insulin action and enlarged pancreatic islets, suggesting a potential link to conditions like type 2 diabetes and obesity (Banks2005Deletion). Variants in the SOCS7 gene, such as rs8074124, have been associated with obesity and insulin resistance, indicating that SOCS7 may influence metabolic syndrome and related traits (Tellechea2013Common).

SOCS7 is also involved in cancer biology. In bladder cancer cells, SOCS7 is upregulated and acts as a target of microRNA-145, which regulates interferon-beta induction and apoptosis. This suggests that SOCS7 may function as an oncogene in bladder cancer, influencing cell growth and survival (Noguchi2013socs7). Additionally, SOCS7's interaction with PTPN14 in acute liver failure highlights its role in inflammatory responses, where its degradation can exacerbate inflammation (Fu2020PTPN14). These findings underscore the clinical significance of SOCS7 in various metabolic, inflammatory, and oncogenic processes.

## Interactions
SOCS7 interacts with a variety of proteins involved in signal transduction and cellular processes. It is known to associate with the insulin receptor (INSR) and insulin receptor substrates such as IRS1 and IRS4, playing a role in insulin signaling regulation (Banks2005Deletion). SOCS7 can reduce IRS1 protein levels through ubiquitination and proteasome-mediated degradation, indicating its involvement in targeting IRS1 for degradation (Banks2005Deletion).

SOCS7 also interacts with several SH3 domain-containing proteins, including Grb-2, Stat-3, Egfr, Lck, Hck, PLC-γ, and the adaptor molecule Nck (Banks2005Deletion). It has been shown to co-precipitate with vinexin, a cytoskeletal molecule, and colocalizes with actin near the cell membrane, suggesting a role in cytoskeletal organization (Martens2004The).

In the context of inflammation, SOCS7 interacts with PTPN14, which promotes its degradation through ubiquitination, affecting the NF-κB signaling pathway. This interaction is significant in regulating inflammatory cytokine expression (Fu2020PTPN14). These interactions highlight SOCS7's multifaceted role in cellular signaling and regulation.


## References


[1. (Fu2020PTPN14) Beibei Fu, Songna Yin, Xiaoyuan Lin, Lei Shi, Yu Wang, Shanfu Zhang, Qingting Zhao, Zhifeng Li, Yanling Yang, and Haibo Wu. Ptpn14 aggravates inflammation through promoting proteasomal degradation of socs7 in acute liver failure. Cell Death &amp; Disease, September 2020. URL: http://dx.doi.org/10.1038/s41419-020-03014-7, doi:10.1038/s41419-020-03014-7. This article has 16 citations.](https://doi.org/10.1038/s41419-020-03014-7)

[2. (Tellechea2013Common) M.L. Tellechea, A. Penas Steinhardt, G. Rodriguez, M.J. Taverna, E. Poskus, and G. Frechtel. Common variants in socs7 gene predict obesity, disturbances in lipid metabolism and insulin resistance. Nutrition, Metabolism and Cardiovascular Diseases, 23(5):424–431, May 2013. URL: http://dx.doi.org/10.1016/j.numecd.2011.10.005, doi:10.1016/j.numecd.2011.10.005. This article has 7 citations.](https://doi.org/10.1016/j.numecd.2011.10.005)

[3. (Banks2005Deletion) Alexander S. Banks, Jianze Li, Lisa McKeag, Marta L. Hribal, Masaki Kashiwada, Domenico Accili, and Paul B. Rothman. Deletion of socs7 leads to enhanced insulin action and enlarged islets of langerhans. Journal of Clinical Investigation, 115(9):2462–2471, September 2005. URL: http://dx.doi.org/10.1172/jci23853, doi:10.1172/jci23853. This article has 72 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci23853)

[4. (Noguchi2013socs7) S Noguchi, N Yamada, M Kumazaki, Y Yasui, J Iwasaki, S Naito, and Y Akao. Socs7, a target gene of microrna-145, regulates interferon-β induction through stat3 nuclear translocation in bladder cancer cells. Cell Death &amp; Disease, 4(2):e482–e482, February 2013. URL: http://dx.doi.org/10.1038/cddis.2013.11, doi:10.1038/cddis.2013.11. This article has 50 citations.](https://doi.org/10.1038/cddis.2013.11)

[5. (Martens2004The) Nele Martens, Maxime Wery, Ping Wang, Filip Braet, Arieh Gertler, Robert Hooghe, Jean Vandenhaute, and Elisabeth L Hooghe-Peters. The suppressor of cytokine signaling (socs)-7 interacts with the actin cytoskeleton through vinexin. Experimental Cell Research, 298(1):239–248, August 2004. URL: http://dx.doi.org/10.1016/j.yexcr.2004.04.002, doi:10.1016/j.yexcr.2004.04.002. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2004.04.002)